Lymphocyte Kinetics and Outcomes of Chimeric Antigen Receptor T Cell Therapy in Multiple Myeloma With Out of
Sarah Dingli1, Paul Rothweiler1, Moritz Binder2
1Department of Mechanical Engineering and Earl E. Bakken Medical Devices Center, University of Minnesota, Minneapolis, Minnesota, USA.
American Journal of Hematology
|July 15, 2025
Abstract
No abstract available in PubMed .
Keywords:
hematopoiesis‐lymphocytesneoplasia‐myeloma and other plasma cell dyscrasiasoutcomes researchMore Related Videos
08:46A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells
Published on: November 12, 2019
53.5K
08:04In Vitro Tumor Cell Rechallenge For Predictive Evaluation of Chimeric Antigen Receptor T Cell Antitumor Function
Published on: February 27, 2019
11.9K
